|
Q3 FY2026
As of Sep 25, 2026
|
Q2 FY2026
As of Jun 26, 2026
|
Q1 FY2026
As of Mar 27, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 26, 2025
|
Q2 FY2025
As of Jun 27, 2025
|
Q1 FY2025
As of Mar 28, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 27, 2024
|
Q2 FY2024
As of Jun 28, 2024
|
Q1 FY2024
As of Mar 29, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 29, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jul 1, 2022
|
Q1 FY2022
As of Apr 1, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and equivalents | ||||||||||||||||||||
| Trade accounts receivable, less allowance for doubtful accounts of $122 and $114, respectively | ||||||||||||||||||||
| Inventories: | ||||||||||||||||||||
| Finished goods | ||||||||||||||||||||
| Work in process | ||||||||||||||||||||
| Raw materials | ||||||||||||||||||||
| Total inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets, discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net of accumulated depreciation of $5,042 and $4,767, respectively | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other assets, discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Notes payable and current portion of long-term debt | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Current liabilities, discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Long-term liabilities, discontinued operations | ||||||||||||||||||||
| Preferred stock, no par value, 15.0 million shares authorized; no shares issued and outstanding as of December 31, 2023; 1.72 million shares of 5.00% Mandatory Convertible Preferred Stock, Series B, issued and outstanding as of December 31, 2022 | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock - $0.01 par value, 2.0 billion shares authorized; 888.8 million issued and 703.4 million outstanding as of September 25, 2026; 886.9 million issued and 706.9 million outstanding as of December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total Danaher stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
